Pro company pages include CSV downloads for statements, ratios, chart data, and transcript indexes.
JPX · JP
Chemical supplier with polyimide and specialty materials for electronics and semiconductor applications.
High-performance films and chemicals support advanced packaging and electronics manufacturing.
Price
$3205.00
Change
-85.00 (-2.58%)
Market cap
$311.3B
52w range
$2184–$3350
Exchange
JPX
Country
JP
Jason's Chips
Subscribe or sign in with your Substack email for charts, exports, estimates, transcripts, filings, earnings, and news.
Daily close for UBE Corporation
Download statements, ratios, chart data, and transcript indexes.
Revenue, gross profit, R&D, operating income, EBITDA, net income, and EPS.
Cash, receivables, inventory, PP&E, assets, debt, liabilities, and equity.
Operating cash flow, capital expenditures, and free cash flow.
Enterprise value, valuation multiples, returns, yields, and cash conversion.
Margins, liquidity ratios, valuation ratios, leverage, and per-share metrics.
Five years of daily close and volume data powering the company chart.
Available earnings-call transcript dates by fiscal year and quarter.
| Period | Revenue avg | Revenue range | EPS avg | EPS range | EBITDA avg | EBIT avg | Net income avg | SG&A avg | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| 2027-03-31 | $472.02B | $459.06B - $488.36B | $258.68 | $250.03 - $278.26 | $69.94B | $39.33B | $25.27B | $61.64B | 4 rev / 4 EPS |
| 2028-03-31 | $472.26B | $461.30B - $488.90B | $274.10 | $231.91 - $336.78 | $69.98B | $39.35B | $28.48B | $61.67B | 5 rev / 5 EPS |
| 2029-03-31 | $449.40B | $441.15B - $457.65B | $303.32 | $257.30 - $373.76 | $66.59B | $37.45B | $30.85B | $58.69B | 4 rev / 4 EPS |
| 2030-03-31 | $459.93B | $448.28B - $476.00B | $304.13 | $294.11 - $317.94 | $68.15B | $38.33B | $29.55B | $60.06B | 3 rev / 2 EPS |
| 2031-03-31 | $478.10B | $465.98B - $494.80B | $358.75 | $346.93 - $375.04 | $70.84B | $39.84B | $34.85B | $62.43B | 2 rev / 3 EPS |
| Period | Revenue avg | Revenue range | EPS avg | EPS range | EBITDA avg | EBIT avg | Net income avg | SG&A avg | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $108.05B | $104.10B - $112.00B | $0.00 | $0.00 - $0.00 | $16.01B | $9.00B | $0 | $14.11B | 2 rev / 0 EPS |
| 2026-09-30 | $115.40B | $110.80B - $120.00B | $0.00 | $0.00 - $0.00 | $17.10B | $9.62B | $0 | $15.07B | 2 rev / 0 EPS |
| 2026-12-31 | $120.30B | $115.70B - $124.90B | $0.00 | $0.00 - $0.00 | $17.83B | $10.02B | $0 | $15.71B | 1 rev / 0 EPS |
| 2027-03-31 | $126.70B | $121.85B - $131.55B | $0.00 | $0.00 - $0.00 | $18.77B | $10.56B | $0 | $16.55B | 1 rev / 0 EPS |
No price target summary on file.
No grade actions on file.
| Date | Strong buy | Buy | Hold | Sell | Strong sell |
|---|---|---|---|---|---|
| 2026-06-01 | 1 | 1 | 3 | 0 | 0 |
| 2026-05-01 | 1 | 1 | 3 | 0 | 0 |
| 2026-04-01 | 1 | 1 | 3 | 0 | 0 |
| 2026-03-01 | 1 | 1 | 3 | 0 | 0 |
| 2026-02-01 | 1 | 1 | 3 | 0 | 0 |
| 2026-01-01 | 1 | 1 | 3 | 0 | 0 |
| 2025-12-01 | 2 | 1 | 3 | 0 | 0 |
| 2025-11-01 | 2 | 1 | 3 | 0 | 0 |
| Period | Revenue | Gross profit | Gross margin | R&D | Operating income | EBITDA | Net income | EPS |
|---|---|---|---|---|---|---|---|---|
| FY 2026 | $462.34B | $103.46B | 22.4% | $0 | $18.94B | $61.66B | $23.87B | $245.76 |
| FY 2025 | $486.80B | $91.37B | 18.8% | $9.92B | $18.05B | $18.26B | -$4.82B | $-49.60 |
| FY 2024 | $468.24B | $86.99B | 18.6% | $10.30B | $22.46B | $62.81B | $28.98B | $298.59 |
| FY 2023 | $494.74B | $82.80B | 16.7% | $10.42B | $16.21B | $23.63B | -$7.03B | $-72.54 |
| FY 2022 | $655.26B | $128.24B | 19.6% | $11.79B | $44.04B | $74.39B | $24.50B | $249.31 |
| FY 2021 | $613.89B | $104.91B | 17.1% | $11.38B | $25.90B | $59.75B | $22.94B | $226.79 |
| FY 2020 | $667.89B | $118.95B | 17.8% | $12.89B | $34.03B | $71.11B | $22.98B | $227.33 |
| FY 2019 | $730.16B | $130.17B | 17.8% | $12.10B | $44.55B | $81.12B | $32.50B | $312.36 |
| FY 2018 | $695.57B | $135.66B | 19.5% | $13.21B | $50.25B | $85.75B | $31.68B | $301.65 |
| FY 2017 | $616.56B | $115.90B | 18.8% | $13.62B | $34.82B | $69.45B | $24.18B | $228.50 |
| FY 2016 | $641.75B | $121.71B | 19.0% | $13.71B | $41.26B | $76.98B | $19.11B | $180.60 |
| FY 2015 | $641.76B | $102.72B | 16.0% | $13.86B | $24.00B | $57.73B | $14.65B | $138.50 |
| Period | Operating cash flow | Capex | Free cash flow |
|---|---|---|---|
| FY 2026 | $59.98B | $72.45B | -$12.46B |
| FY 2025 | $35.84B | $58.93B | -$23.09B |
| FY 2024 | $52.96B | $30.97B | $21.99B |
| FY 2023 | $18.13B | $26.83B | -$8.70B |
| FY 2022 | $32.71B | $36.38B | -$3.67B |
| FY 2021 | $66.05B | $38.21B | $27.85B |
| FY 2020 | $68.49B | $42.65B | $25.84B |
| FY 2019 | $50.46B | $42.76B | $7.70B |
| FY 2018 | $73.39B | $33.77B | $39.62B |
| FY 2017 | $53.42B | $41.87B | $11.55B |
| FY 2016 | $68.63B | $34.48B | $34.14B |
| FY 2015 | $62.19B | $41.96B | $20.23B |
| Period | Cash + ST inv. | Receivables | Inventory | PP&E | Assets | Debt | Net debt | Liabilities | Equity |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | $55.83B | $102.12B | $136.70B | $295.89B | $946.31B | $358.17B | $302.34B | $491.38B | $437.21B |
| FY 2025 | $115.97B | $106.48B | $121.99B | $222.70B | $865.67B | $330.54B | $214.57B | $453.66B | $395.10B |
| FY 2024 | $36.36B | $107.70B | $133.95B | $222.16B | $789.03B | $213.43B | $177.07B | $359.68B | $408.75B |
| FY 2023 | $31.18B | $107.00B | $127.01B | $209.04B | $732.68B | $218.10B | $186.93B | $351.05B | $361.68B |
| FY 2022 | $79.49B | $171.36B | $124.71B | $332.76B | $837.95B | $241.81B | $162.32B | $443.92B | $369.65B |
| FY 2021 | $80.30B | $149.05B | $87.83B | $331.22B | $769.71B | $214.77B | $134.46B | $389.07B | $359.56B |
| FY 2020 | $41.23B | $157.63B | $93.74B | $330.04B | $727.27B | $190.72B | $149.49B | $372.82B | $332.97B |
| FY 2019 | $32.90B | $171.01B | $96.76B | $331.32B | $740.29B | $187.30B | $154.40B | $385.73B | $330.15B |
| FY 2018 | $49.06B | $162.16B | $90.93B | $334.26B | $742.45B | $198.89B | $149.83B | $405.58B | $316.02B |
| FY 2017 | $36.63B | $157.32B | $82.80B | $331.44B | $709.38B | $213.66B | $177.02B | $398.98B | $287.22B |
| FY 2016 | $42.46B | $138.87B | $76.08B | $323.80B | $679.78B | $219.74B | $177.27B | $389.20B | $267.16B |
| FY 2015 | $38.11B | $144.19B | $78.45B | $347.44B | $711.55B | $242.71B | $204.60B | $420.95B | $263.89B |
| Period | Gross margin | Op margin | Net margin | Current | Quick | ROE | ROIC | EV / sales | EV / EBITDA | FCF yield | R&D / rev. | Cash cycle |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | 22.4% | 4.1% | 5.2% | 1.5x | 0.8x | 5.5% | 1.8% | 1.2x | 8.7x | -5.3% | 0.0% | 165d |
| FY 2025 | 18.8% | 3.7% | -1.0% | 1.8x | 1.2x | -1.2% | 2.0% | 0.9x | 23.3x | -10.9% | 2.0% | 148d |
| FY 2024 | 18.6% | 4.8% | 6.2% | 1.5x | 0.8x | 7.1% | 2.8% | 0.9x | 6.9x | 8.5% | 2.2% | 153d |
| FY 2023 | 16.7% | 3.3% | -1.4% | 1.6x | 0.9x | -1.9% | 2.6% | 0.8x | 16.3x | -4.4% | 2.1% | 130d |
| FY 2022 | 19.6% | 6.7% | 3.7% | 1.6x | 1.1x | 6.6% | 4.7% | 0.5x | 4.8x | -1.9% | 1.8% | 105d |
| FY 2021 | 17.1% | 4.2% | 3.7% | 1.7x | 1.2x | 6.4% | 4.2% | 0.6x | 6.2x | 11.7% | 1.9% | 86d |
| FY 2020 | 17.8% | 5.1% | 3.4% | 1.5x | 1.1x | 6.9% | 4.4% | 0.5x | 4.5x | 15.4% | 1.9% | 87d |
| FY 2019 | 17.8% | 6.1% | 4.5% | 1.4x | 1.0x | 9.8% | 5.9% | 0.6x | 5.0x | 3.1% | 1.7% | 82d |
| FY 2018 | 19.5% | 7.2% | 4.6% | 1.3x | 0.9x | 10.0% | 6.5% | 0.7x | 5.6x | 12.1% | 1.9% | 76d |
| FY 2017 | 18.8% | 5.6% | 3.9% | 1.2x | 0.9x | 8.4% | 4.7% | 0.7x | 6.4x | 4.3% | 2.2% | 86d |
| FY 2016 | 19.0% | 6.4% | 3.0% | 1.2x | 0.9x | 7.2% | 5.2% | 0.6x | 5.0x | 16.2% | 2.1% | 80d |
| FY 2015 | 16.0% | 3.7% | 2.3% | 1.2x | 0.9x | 5.6% | 3.3% | 0.6x | 7.0x | 10.2% | 2.2% | 78d |
| Period | Revenue | Gross profit | R&D | Op income | Net income | EPS | FCF | Capex | Cash + ST inv. | Inventory | Assets | Debt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | -5.0% | +13.2% | -100.0% | +5.0% | +595.7% | +595.5% | +46.0% | -22.9% | -51.9% | +12.1% | +9.3% | +8.4% |
| FY 2025 | +4.0% | +5.0% | -3.7% | -19.6% | -116.6% | -116.6% | -205.0% | -90.3% | +219.0% | -8.9% | +9.7% | +54.9% |
| FY 2024 | -5.4% | +5.1% | -1.2% | +38.5% | +512.0% | +511.6% | +352.7% | -15.4% | +16.6% | +5.5% | +7.7% | -2.1% |
| FY 2023 | -24.5% | -35.4% | -11.6% | -63.2% | -128.7% | -129.1% | -137.2% | +26.3% | -60.8% | +1.8% | -12.6% | -9.8% |
| FY 2022 | +6.7% | +22.2% | +3.6% | +70.0% | +6.8% | +9.9% | -113.2% | +4.8% | -1.0% | +42.0% | +8.9% | +12.6% |
| FY 2021 | -8.1% | -11.8% | -11.7% | -23.9% | -0.2% | -0.2% | +7.8% | +10.4% | +94.8% | -6.3% | +5.8% | +12.6% |
| FY 2020 | -8.5% | -8.6% | +6.5% | -23.6% | -29.3% | -27.2% | +235.6% | +0.3% | +25.3% | -3.1% | -1.8% | +1.8% |
| FY 2019 | +5.0% | -4.0% | -8.4% | -11.3% | +2.6% | +3.6% | -80.6% | -26.6% | -32.9% | +6.4% | -0.3% | -5.8% |
| FY 2018 | +12.8% | +17.1% | -3.1% | +44.3% | +31.0% | +32.0% | +243.0% | +19.3% | +33.9% | +9.8% | +4.7% | -6.9% |
| FY 2017 | -3.9% | -4.8% | -0.6% | -15.6% | +26.6% | +26.5% | -66.2% | -21.4% | -13.7% | +8.8% | +4.4% | -2.8% |
| FY 2016 | -0.0% | +18.5% | -1.1% | +71.9% | +30.5% | +30.4% | +68.7% | +17.8% | +11.4% | -3.0% | -4.5% | -9.5% |
| FY 2015 | -1.3% | -1.4% | -0.4% | -1.7% | +16.1% | +13.9% | +2477.5% | -15.7% | +24.7% | -4.8% | +1.5% | -2.4% |
Revenue segmentation data unavailable.
No transcripts on file.
2026-08-07